Navone NM - Search Results

1

Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer.

Labanca E, Yang J, Shepherd PDA, Wan X, Starbuck MW, Guerra LD, Anselmino N, Bizzotto JA, Dong J, Chinnaiyan AM, Ravoori MK, Kundra V, Broom BM, Corn PG, Troncoso P, Gueron G, Logothethis CJ, Navone NM. Labanca E, et al. Among authors: navone nm. Eur Urol Oncol. 2022 Apr;5(2):164-175. doi: 10.1016/j.euo.2021.10.001. Epub 2021 Nov 11. Eur Urol Oncol. 2022. PMID: 34774481 Free article.

2

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.

Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC, Conti CJ. Navone NM, et al. J Natl Cancer Inst. 1993 Oct 20;85(20):1657-69. doi: 10.1093/jnci/85.20.1657. J Natl Cancer Inst. 1993. PMID: 7692074

3

Frequency and characterization of p53 mutations in clinically localized prostate cancer.

Hall MC, Navone NM, Troncoso P, Pollack A, Zagars GK, von Eschenbach AC, Conti CJ, Chung LW. Hall MC, et al. Among authors: navone nm. Urology. 1995 Mar;45(3):470-5. doi: 10.1016/s0090-4295(99)80018-1. Urology. 1995. PMID: 7879337

4

Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer.

McDonnell TJ, Navone NM, Troncoso P, Pisters LL, Conti C, von Eschenbach AC, Brisbay S, Logothetis CJ. McDonnell TJ, et al. Among authors: navone nm. J Urol. 1997 Feb;157(2):569-74. J Urol. 1997. PMID: 8996359

5

Modulation of cellular proliferation and production of prostate-specific antigen and matrix adhesion molecules in human prostate carcinoma cells by polypeptide growth factors: comparative analyses of MDA PCa2a with established cell lines.

Rajagopal S, Navone NM, Troncoso P, Fritsche HA, Chakrabarty S. Rajagopal S, et al. Among authors: navone nm. Int J Oncol. 1998 Mar;12(3):589-95. doi: 10.3892/ijo.12.3.589. Int J Oncol. 1998. PMID: 9472097

6

Prolonged survival with metastatic prostate cancer to bone.

Pisters LL, Troncoso P, Navone N. Pisters LL, et al. J Urol. 1998 Jun;159(6):2100. doi: 10.1016/S0022-5347(01)63271-3. J Urol. 1998. PMID: 9598540 No abstract available.

7

Structural alterations of chromosome 5 in twelve human prostate cancer cell lines.

Ozen M, Navone NM, Multani AS, Troncoso P, Logothetis CJ, Chung LW, von Eschenbach AC, Pathak S. Ozen M, et al. Among authors: navone nm. Cancer Genet Cytogenet. 1998 Oct 15;106(2):105-9. doi: 10.1016/s0165-4608(98)00051-x. Cancer Genet Cytogenet. 1998. PMID: 9797773

8

Establishment of two human prostate cancer cell lines derived from a single bone metastasis.

Navone NM, Olive M, Ozen M, Davis R, Troncoso P, Tu SM, Johnston D, Pollack A, Pathak S, von Eschenbach AC, Logothetis CJ. Navone NM, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2493-500. Clin Cancer Res. 1997. PMID: 9815652

9

p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential.

Navone NM, Labate ME, Troncoso P, Pisters LL, Conti CJ, von Eschenbach AC, Logothetis CJ. Navone NM, et al. J Urol. 1999 Jan;161(1):304-8. J Urol. 1999. PMID: 10037428

10

Model systems of prostate cancer: uses and limitations.

Navone NM, Logothetis CJ, von Eschenbach AC, Troncoso P. Navone NM, et al. Cancer Metastasis Rev. 1998-1999;17(4):361-71. doi: 10.1023/a:1006165017279. Cancer Metastasis Rev. 1998. PMID: 10453280 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page